{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:38:33Z","timestamp":1784864313720,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009874","name":"Universit\u00e9 de Sherbrooke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009874","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centre des neurosciences de Sherbrooke"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.physbeh.2018.03.036","type":"journal-article","created":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T06:31:37Z","timestamp":1523082697000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The 5\u03b1-reductase inhibitor finasteride increases suicide-related aggressive behaviors and blocks clozapine-induced beneficial effects in an animal model of schizophrenia"],"prefix":"10.1016","volume":"191","author":[{"given":"Caroline","family":"Maurice-G\u00e9linas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Deslauriers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Monpays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Sarret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Grignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2018.03.036_bb0005","first-page":"247","article-title":"The Lifetime Risk of Suicide in Schizophrenia","volume":"62","author":"Palmer","year":"2005"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0010","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1586\/ern.10.82","article-title":"Suicide in schizophrenia","volume":"10","author":"Carlborg","year":"2010","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.schres.2009.04.006","article-title":"CSF 5-HIAA, attempted suicide and suicide risk in schizophrenia spectrum psychosis","volume":"112","author":"Carlborg","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0020","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/archpsyc.1976.01770100055005","article-title":"5-hiaa in the cerebrospinal fluid: a biochemical suicide predictor?","volume":"33","author":"\u00c5sberg","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1600-0447.2005.00639.x","article-title":"CSF 5-HIAA, suicide intent and hopelessness in the prediction of early suicide in male high-risk suicide attempters","volume":"113","author":"Samuelsson","year":"2006","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0030","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.2147\/NDT.S107178","article-title":"Risk factors for suicide among patients with schizophrenia: a cohort study focused on cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid","volume":"Volume 12","author":"Neider","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archpsyc.60.1.82","article-title":"Clozapine treatment for suicidality in schizophrenia (InterSePT)","volume":"60","author":"Meltzer","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300015","article-title":"Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents","volume":"28","author":"Marx","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0050","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0893-133X(01)00254-8","article-title":"Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat","volume":"25","author":"Barbaccia","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0055","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.pbb.2006.07.026","article-title":"Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy?","volume":"84","author":"Marx","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0060","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1096\/fasebj.6.6.1347506","article-title":"Neuroactive steroids","volume":"6","author":"Paul","year":"1992","journal-title":"FASEB J."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0306-4530(02)00064-1","article-title":"Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties","volume":"28","author":"Rupprecht","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-6147(99)01318-8","article-title":"Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders","volume":"20","author":"Gasior","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1027\/0227-5910\/a000280","article-title":"Exploratory investigation of biomarker candidates for suicide in schizophrenia and bipolar disorder: preliminary findings of altered neurosteroid levels","volume":"36","author":"Youssef","year":"2015","journal-title":"Crisis"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0080","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.schres.2013.09.001","article-title":"Medication and suicide risk in schizophrenia: a nested case-control study","volume":"150","author":"Reutfors","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0085","first-page":"65","article-title":"Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder: A genome-wide association study","volume":"75","author":"Amare","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0090","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/npp.2017.7","article-title":"Maternal immune activation causes behavioral impairments and altered cerebellar cytokine and synaptic protein expression","volume":"42","author":"Pendyala","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0095","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbi.2014.02.007","article-title":"Maternal immune activation leads to activated inflammatory macrophages in offspring","volume":"38","author":"Onore","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.physbeh.2016.01.002","article-title":"A two-hit model of suicide-trait-related behaviors in the context of a schizophrenia-like phenotype: distinct effects of lithium chloride and clozapine","volume":"156","author":"Deslauriers","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0105","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1371\/journal.pmed.0030107","article-title":"Trends in suicidology: personality as an endophenotype for molecular genetic investigations","volume":"3","author":"Savitz","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0110","first-page":"398","article-title":"Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours","volume":"30","author":"Turecki","year":"2005","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0115","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1176\/appi.ajp.160.4.636","article-title":"The endophenotype concept in psychiatry: etymology and strategic intentions","volume":"160","author":"Gottesman","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.50","article-title":"Animal models to improve our understanding and treatment of suicidal behavior","volume":"7","author":"Gould","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s13353-012-0113-1","article-title":"Endophenotypes as a measure of suicidality","volume":"53","author":"Chistiakov","year":"2012","journal-title":"J. Appl. Genet."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0130","series-title":"Endophenotypes and suicide behaviour, Actas Esp Psiquiatr","first-page":"61","volume":"39","author":"Jim\u00e9nez-Trevino","year":"2011"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0135","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.neuroscience.2007.02.051","article-title":"Sex differences in the effect of finasteride on acute ethanol withdrawal severity in C57BL\/6J and DNA\/2J mice","volume":"146","author":"Gorin-Meyer","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0140","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002130100763","article-title":"Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?","volume":"156","author":"Ouagazzal","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1527-3458.2006.00053.x","article-title":"A new look at the 5alpha-reductase inhibitor finasteride","volume":"12","author":"a Finn","year":"2006","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0150","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","article-title":"Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies","volume":"156","author":"Braff","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbr.2009.03.028","article-title":"Behavioral abnormality and pharmacologic response in social isolation-reared mice","volume":"202","author":"Koike","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0165","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0006-3223(02)01418-X","article-title":"Monoamine oxidase inhibition during brain development induces pathological aggressive behavior in mice","volume":"52","author":"Mejia","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0170","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1471-4159.2012.07739.x","article-title":"Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity","volume":"121","author":"Angoa-P\u00e9rez","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.psyneuen.2015.09.014","article-title":"Psychoneuroendocrinology the neurosteroidogenic enzyme 5 alpha-reductase modulates the role of D 1 dopamine receptors in rat sensorimotor gating","volume":"63","author":"Frau","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0180","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.psyneuen.2012.07.014","article-title":"Inhibition of 5 a -reductase attenuates behavioral effects of D 1 -, but not D 2 -like receptor agonists in C57BL\/6 mice","volume":"38","author":"Frau","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0185","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.schres.2015.04.044","article-title":"Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress","volume":"168","author":"Frau","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbr.2015.04.023","article-title":"Finasteride administration potentiates the disruption of prepulse inhibition induced by forced swim stress","volume":"289","author":"Pallar\u00e8s","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0195","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.euroneuro.2015.11.006","article-title":"An observational study of clozapine induced sedation and its pharmacological management","volume":"26","author":"Perdigu\u00e9s","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0205","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00023210-200721110-00004","article-title":"Adverse effects of atypical antipsychotics : differential risk and clinical implications","volume":"21","author":"Haddad","year":"2007","journal-title":"CNS Drugs."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4002066","article-title":"Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles","volume":"13","author":"Nasrallah","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00213-011-2471-5","article-title":"Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo","volume":"220","author":"Humbert-Claude","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.euroneuro.2016.10.007","article-title":"Sedative effect of clozapine is a function of 5-HT2A and environmental novelty","volume":"27","author":"Joshi","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0225","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1038\/npp.2012.139","article-title":"Clozapine-induced locomotor suppression is mediated by 5-HT2A receptors in the forebrain","volume":"37","author":"McOmish","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0230","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/npp.2012.81","article-title":"Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine","volume":"37","author":"Williams","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0235","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pnpbp.2005.08.020","article-title":"Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in rats","volume":"30","author":"Ortega-Alvaro","year":"2006","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0240","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABA(A) receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0245","first-page":"232","article-title":"Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor","author":"Majewska","year":"1985","journal-title":"Science (80-.)"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0250","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0896-6273(90)90202-Q","article-title":"Neurosteroids act on recombinant","volume":"4","author":"Puia","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0255","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0165-0173(01)00129-1","article-title":"The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5alpha-dihydroprogesterone in psychiatric disorders","volume":"37","author":"a Guidotti","year":"2001","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0260","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/10253890500159022","article-title":"Social isolation stress-induced aggression in mice: a model to study the pharmacology of neurosteroidogenesis","volume":"8","author":"Matsumoto","year":"2005","journal-title":"Stress"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0265","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1097\/01.wnr.0000234752.03808.b2","article-title":"Neurosteroids regulate mouse aggression induced by anabolic androgenic steroids","volume":"17","author":"Pibiri","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0270","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1007\/s11064-008-9718-5","article-title":"Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice","volume":"33","author":"Pinna","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0275","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1073\/pnas.0337642100","article-title":"In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine","volume":"100","author":"Pinna","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0280","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1471-4159.2000.0750732.x","article-title":"Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA a receptor function in rat brain","volume":"75","author":"Serra","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0285","first-page":"607","article-title":"Violence and schizophrenia: clozapine as a specific antiaggressive agent","volume":"23","author":"Buckley","year":"1995","journal-title":"Bull. Am. Acad. Psychiatry Law."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0290","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/schbul\/sbt117","article-title":"Depression and impulsivity as pathways to violence: implications for antiaggressive treatment","volume":"40","author":"Krakowski","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0295","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/archpsyc.63.6.622","article-title":"Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder","volume":"63","author":"Krakowski","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.physbeh.2018.03.036_bb0300","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1742-1241.2008.01797.x","article-title":"Heterogeneity of violence in schizophrenia and implications for long-term treatment","volume":"62","author":"Volavka","year":"2008","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0305","first-page":"43","article-title":"The effects of clozapine on aggression and substance abuse in schizophrenic patients","volume":"60","author":"Volavka","year":"1999","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.physbeh.2018.03.036_bb0310","author":"Stahl","year":"2014","journal-title":"Stahl's Psychopharmacology"}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938418301677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938418301677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T15:56:32Z","timestamp":1617638192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938418301677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":62,"alternative-id":["S0031938418301677"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2018.03.036","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 5\u03b1-reductase inhibitor finasteride increases suicide-related aggressive behaviors and blocks clozapine-induced beneficial effects in an animal model of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2018.03.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}